Access for All

Early detection and treatment are important means of protecting patients. Unnecessary barriers to access put that in jeopardy. @WaysandMeansGOP and @WaysMeansCmte should focus on removing barriers to prevention and innovation waysandmeans.house.gov/event/health-s…

As lawmakers gather for the Ways & Means hearing on kidney health, outdated policies continue to delay care that could prevent serious illness. @WaysandMeansGOP @WaysMeansCmte should prioritize timely access to the right care. waysandmeans.house.gov/event/health-s…

Patients deserve access to preventive tools and innovative treatments without unneeded barriers. @WaysandMeansGOP @WaysMeansCmte must keep unnecessary hurdles top of mind at their hearing on kidney health. waysandmeans.house.gov/event/health-s…

For too long, insurance companies have put cost savings above patients’ health. @CZ’s new blog post dives into the ways prior authorization slows down and prevents patients from accessing their treatment. campaign4access.com/news/prior-aut…

Patients with chronic, rare, or life-threatening diseases face many obstacles in day-to-day life. Prior authorization requirements in unnecessary situations shouldn’t add another barrier to getting treatment. Read @CZ’s new blog on the policy here: campaign4access.com/news/prior-aut…

Prior authorization and CED policies burden physicians and block patient access. Read Access for All’s new question for the record asking what @SenateAging & @SenateAgingDems will do to reduce these barriers: campaign4access.com/news/access-fo…

Washington policies are straining providers and preventing patients from accessing life-saving treatments. Read AFA’s question to @SenateAging & @SenateAgingDems following their hearing on physician burnout and reduced patient access. campaign4access.com/news/access-fo…

After the recent @SenateAging @SenateAgingDems hearing on physician burnout and reduced patient access, AFA submitted a question for the record highlighting the need to reform prior authorization and CED requirements that delay care and strain providers. campaign4access.com/news/access-fo…

Washington must unleash innovation and ensure patients can access these developments once created. Check out AFA’s question to the Senate HELP Committee following their recent NIH modernization hearing. campaign4access.com/news/access-fo…

Biomarker tests are cutting-edge diagnostic tools that can increase early detection of Alzheimer's. The ASAP Act would expand Medicare coverage for Alzheimer’s tests, and it’s gaining support! More from @RealJoeGrogan and @SuePeschin on @DCEKGpodcast: podcasts.apple.com/us/podcast/alz…

Early detection of Alzheimer’s disease is improving with new FDA-approved blood tests, but policy barriers prevent widespread usage. Learn more from @RealJoeGrogan and @SuePeschin on @DCEKGpodcast. podcasts.apple.com/us/podcast/alz…

Amyloid plaque inhibitors are a cutting-edge Alzheimer’s disease treatment. However, access to this treatment is inhibited by policies that require patients to jump through unnecessary hoops. We must unleash Alzheimer’s treatments to make America healthy. podcasts.apple.com/us/podcast/alz…

Because of Coverage with Evidence Development (CED), tens of thousands of Alzheimer’s patients are missing out on tools that could slow progression and improve quality of life. @RealJoeGrogan and @SuePeschin discuss this issue and others on @DCEKGpodcast. podcasts.apple.com/us/podcast/alz…

The Coverage with Evidence Development (CED) program places diagnostic tests & treatments beyond the reach of many patients. Listen to @RealJoeGrogan and @SuePeschin on @DCEKGpodcast to hear more about ways policymakers can help Alzheimer’s patients. podcasts.apple.com/us/podcast/alz…

An early Alzheimer’s diagnosis is more attainable than ever, but policy barriers have created friction points in every step of the process. @RealJoeGrogan and @SuePeschin talk on @DCEKGpodcast about how policymakers can prioritize early detection. podcasts.apple.com/us/podcast/alz…

Patients should not have to deal with barriers preventing access to care. Prior authorization can delay or deny coverage for necessary and approved treatments. Congressional action on prior auth reform will help patients get the care they need. dcjournal.com/prior-authoriz…

Congress should stop insurers from using prior auth to prevent patients from getting the treatment their doctors prescribe. Patients deserve quick access to treatment their doctors know they need – not a system that delays or denies care to cut costs. dcjournal.com/prior-authoriz…

Patients shouldn’t need to navigate red tape to access the treatments their doctors prescribe. Prior authorization requirements block patients from the medications they need. Congress should remove unnecessary prior auth barriers to put patients first. axios.com/2026/02/09/med…

A new @WSJopinion piece showcases a retired doctor’s experience being diagnosed with Alzheimer’s Disease at just 57 years old. Dr. Beasley’s story highlights the shows the importance of early diagnosis and access to treatment. Learn more: wsj.com/opinion/i-caug…

Fantastic new @WSJopinion piece highlights the importance of early diagnosis for Alzheimer’s disease. Removing barriers to access for early detection and treatment tools can save lives. wsj.com/opinion/i-caug…